Table 2.
C5aR2 KO on C57BL/6 background.
| Source | Disease model | Properties of C5aR2 | Refs |
|---|---|---|---|
| B. Lu, Harvard Medical School, USA |
IC-induced acute lung injury | Anti-inflammation | [34] |
| Anti-mMPO-induced ANCA NCGN |
Anti-inflammation | [88] | |
| CLP-induced sepsis and in vitro assays on leukocytes |
Proinflammation and indispensable for HMGB-1 release |
[7] | |
| CLP-induced sepsis | On CMs—proinflammation and causes cardiac dysfunction |
[75, 76, 78] | |
| Acute pyelonephritis | Proinflammation | [72] | |
| Renal I/R injury | Proinflammation | [73] | |
| Experimental cerebral malaria | No function※ | [124] | |
| S. aureus bloodstream infection | Anti-inflammation | [125] | |
| AKI induced by LPS, IC, or C5a | Proinflammation | [71] | |
| Genotyping and breeding in University of Michigan according to the method of Dr. Craig Gerard |
CLP-induced sepsis | Indispensable for G-CSF release by macrophages | [79] |
| CLP-induced sepsis | On CMs—proinflammation: activation of the cardiac NLRP3 inflammasome |
[77] | |
| Professor A. Klos, Hannover Medical School, Germany | Wire-induced endothelial denudation of the carotid artery, diet-induced atherosclerosis | Proinflammation | [66] |
| The Jackson Laboratory | In vitro atherosclerosis model | On PBMCs and BMDMs—proinflammation | [87] |
| Lexicon Genetics, the Woodlands, Texas | Thioglycollate-induced peritonitis and air-pouch inflammation |
Proinflammation | [68] |
| LPS-induced septic shock | Anti-inflammation | [68] |